InsiderTrades

Form 4 for RIME Algorhythm Holdings, Inc.

Accepted 2025-02-18 00:00:00 ET · period of report 2025-02-13 · accession 0001493152-25-007202 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-02-18 2025-02-13 RIME Andre Alex CFO, GC A - Grant $0.00 +23.8K 23.8K New $0
D 2025-02-18 2025-02-13 RIME Andre Alex CFO, GC A - Grant $0.00 +23.8K 23.8K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-02-13 A A 23,818 $0.00 23,818 D — — (F1) The reported transaction involved the Reporting Person's receipt of a restricted stock award for 23,818 shares of the Issuer's common stock. The restricted stock award was granted by the Board of Directors of the Issuer as an inducement grant pursuant to the Nasdaq Listing Rule 5635(c)(4). Twenty-five percent (25%) of the total number of shares subject to the restricted stock award shall vest on the first anniversary of the grant date and six and one-quarter percent (6.25%) of the remaining shares shall vest each quarter thereafter.
2 Derivative Stock Option (right to buy) 2025-02-13 A A 23,818 $0.00 23,818 D $2.78 · — to 2035-02-13 23,818 Common Stock (F2) The reported transaction involved the Reporting Person's receipt of a non-qualified stock option to purchase 23,818 shares of the Issuer's common stock. The non-qualified stock option was granted by the Board of Directors of the Issuer as an inducement grant pursuant to the Nasdaq Listing Rule 5635(c)(4). (F3) Twenty-five percent (25%) of the total number of shares subject to the non-qualified stock option shall vest and become exercisable on the first anniversary of the grant date and six and one-quarter percent (6.25%) of the remaining shares shall vest and become exercisable each quarter thereafter.